eFFECTOR Therapeutics Inc... (EFTR)

OTC: EFTR · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Mar 06, 2025, 9:31 AM

eFFECTOR Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-35.81M	-22.66M	15.8M	14.21M	-29.74M
Depreciation & Amortization	111K	53K	24K	160K	307K
Stock-Based Compensation	4.59M	5.33M	8.66M	499K	646K
Other Working Capital	830K	1.72M	-393K	-573K	1.8M
Other Non-Cash Items	-130K	-11.3M	-48.59M	122K	2.1M
Deferred Income Tax	n/a	n/a	-539K	-333K	-1.99M
Change in Working Capital	1.69M	2.68M	-238K	-824K	1.07M
Operating Cash Flow	-29.55M	-25.9M	-24.89M	13.84M	-27.6M
Capital Expenditures	-97K	-192K	-42K	-154K	-4K
Cash Acquisitions	n/a	17.67M	607K	n/a	88K
Purchase of Investments	-17.17M	-52.42M	n/a	n/a	n/a
Sales Maturities Of Investments	31.75M	34.75M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-17.67M	607K	n/a	88K
Investing Cash Flow	14.48M	-17.86M	565K	-154K	84K
Debt Repayment	n/a	n/a	5.89M	-2M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-86K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	56K	-34K	52.91M	108K	20.24M
Financial Cash Flow	21.23M	2.77M	58.81M	-1.89M	20.24M
Net Cash Flow	6.17M	-40.99M	34.49M	11.79M	3.43M
Free Cash Flow	-29.65M	-26.09M	-24.93M	13.68M	-27.6M